UroGen Pharma Ltd.

UroGen Pharma Ltd. financial statements

UroGen Pharma Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 109.79M10-K
Net income−USD 153.49M10-K
Cash and equivalentsUSD 110.75M10-Q
Total debtUSD 125M10-K

UroGen Pharma Ltd. financials on 6ix · UroGen Pharma Ltd. on 6ix